1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cancer remedy. Several embolic agents are used by interventional radiologists for the selective occlusion of arteries supplying blood to tumors. The selection of an embolic agent depends on various factors including size of the vessel to be embolized, desired clinical outcome, duration of the vessel to be occluded, and also the intrinsic properties and behavior of the embolic agent. Nanoparticles as drug delivery systems have emerged as a promising technology to treat patients suffering from various types of cancer. Owing to their small size, nanoparticles exhibit unique physicochemical and biological properties, and thus help in overcoming several limitations such as poor bio-distribution, non-specific drug delivery, low therapeutic indices, and lack of water solubility which are mostly associated with conventional drug delivery.

This report studies the global market for NDDS in cancer therapy encompassing three major technologies: embolization particles, liquid embolics and nanoparticles. Each of these technologies has been analyzed in detail from product analysis, market trends, recent developments, future outlook and opportunities, to the competitive landscape. The report provides market size in terms of USD million for each technology for the period 2012 to 2020, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall NDDS in cancer therapy market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. This report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study.

Geographically, the NDDS in cancer therapy market has been classified into four regions namely, North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR for the forecast period from 2014 to 2020 have also been provided in the report. A detailed qualitative analysis of the major factors determining market dynamics such as drivers, restraints and opportunities, along with the market attractiveness analysis are discussed in the market overview section of the NDDS in cancer therapy market report. A section describing the U.S. and EU regulatory pathways has also been included. The study on NDDS in cancer therapy suggests a list of recommendations for new companies willing to enter the market and for existing companies to accentuate shares, which is likely to help in the decision-making process. ANSOFF matrix analysis has also been provided for the key players in this market. The competitive landscape section has been provided for each technology separately and presents the market revenue share of key players in terms of percentage for the year 2013. The market share analysis of key players involved the study of company product portfolio, sales revenue, and geographical presence along with market developments such as new product launch, brand recall, regulatory approvals, etc.

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The key players operating in the NDDS in cancer therapy market are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc. and Terumo Medical Corporation.

The global NDDS in cancer therapy market is segmented as follows:

NDDS in Cancer Therapy Market, by Technology
Embolization Particles
Current Technologies
Drug Eluting Beads
Others (PVA particles, microspheres, gelatin-based)
Emerging Technologies
Selective Internal Radiation Therapy (SIRT)
TheraSphere
SIR-Spheres
Holmium-based Microspheres
Liquid Embolics
Onyx (LES and HD-500)
TRUFILL nBCA LES
Nanoparticles
NDDS in Cancer Therapy Market, by Geography
North America
Embolization Particles
Liquid Embolics
Nanoparticles
Europe
Embolization Particles
Liquid Embolics
Nanoparticles
Asia Pacific
Embolization Particles
Liquid Embolics
Nanoparticles
Rest of the World (RoW)
Embolization Particles
Liquid Embolics
Nanoparticles

Table Of Contents

NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Table of Contents

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Assumptions and Limitations
1.3.3 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global NDDS in Cancer Therapy Market (2013 and 2020)
2.2 Global NDDS in Cancer Therapy Market, by Technology, 2013 (USD Million)
2.3 Comparative Analysis: Global NDDS in Cancer Therapy Market Revenue, by Geography, 2013 and 2020 (Value %)

Chapter 3 Market Overview
3.1 Introduction
3.2 Global Prevalence and Incidence Data
3.2.1 Global Historical Prevalence (Number of Cases), by Major Cancer Type (2008 - 2012)
3.2.2 Global Prevalence Forecast (Number of Cases), by Major Cancer Type (2013 - 2020)
3.2.3 Global Historical Incidence (Number of Cases), by Major Cancer Type (2008 - 2012)
3.2.4 Global Incidence Forecast (Number of Cases), by Major Cancer Type (2013 - 2020)
3.3 Current Major Indications for NDDS in Cancer Therapy
3.3.1 Liver Cancer
3.3.2 Pancreatic Cancer
3.3.3 Bile Duct Cancer
3.3.4 Colorectal Cancer
3.3.5 Arteriovenous Malformations
3.3.6 Hypervascular Malignant Tumors
3.3.7 Aneurysms
3.4 Drivers
3.4.1 Growing incidence of various types of cancer
3.4.2 Clinical benefits of embolic agents and nanoparticles over other therapy and drug delivery systems
3.4.3 Technological advances leading to the development of new and innovative therapy
3.4.4 Expanding therapeutic indications of NDDS
3.5 Restraints
3.5.1 High treatment cost associated with NDDS
3.5.2 Strict regulatory pathway and high cost associated with new product development
3.6 Opportunities
3.6.1 Investing in the development of nano-enabled drug delivery systems
3.7 Regulatory Pathway to Commercialization
3.7.1 U.S. Food and Drug Administration (FDA)
3.7.1.1 Major Steps: U.S. FDA Regulatory Approval Pathway
3.7.2 EU (CE Marking)
3.7.2.1 Major Steps: CE Marking Regulatory Approval Pathway
3.8 Event Impact Analysis
3.9 Market Attractiveness Analysis: Global NDDS in Cancer Therapy Market, by Geography

Chapter 4 Global Embolization Particles Market Revenue, by Type
4.1 Overview
4.1.1 Global Embolization Particles Market Revenue, by Type, 2012 - 2020 (USD Million)
4.2 Current Technologies
4.2.1 Drug Eluting Beads
4.2.1.1 Global Drug Eluting Beads Market Revenue, 2012 - 2020 (USD Million)
4.2.2 Other Current Technologies
4.2.2.1 Global Other Current Technologies Market Revenue, 2012 - 2020 (USD Million)
4.2.2.2 Polyvinyl Alcohol (PVA) Particles
4.2.2.3 Microspheres
4.2.2.4 Gelatin-based Embolization Devices
4.3 Emerging Technologies
4.3.1 Selective Internal Radiation Therapy (SIRT) / Radioembolization
4.3.1.1 Global SIRT/ Radioembolization Market Revenue, 2012 - 2020 (USD Million)
4.3.1.2 SIR-Spheres Microspheres
4.3.1.2.1 Global SIR-Spheres Market Revenue, 2012 - 2020 (USD Million)
4.3.1.3 TheraSphere
4.3.1.3.1 Global TheraSphere Market Revenue, 2012 - 2020 (USD Million)
4.3.2 Holmium-based Microspheres
4.4 Recent Events
4.5 Competitive Analysis
4.5.1 Market Share Analysis: Embolization Particles, by Key Players, 2013 (Value %)

Chapter 5 Global Liquid Embolics Market Revenue, by Brand
5.1 Overview
5.1.1 Global Liquid Embolics Market Revenue, by Brand, 2012 - 2020 (USD Million)
5.1.2 Onyx
5.1.2.1 Global Onyx Devices Market Revenue, 2012 - 2020 (USD Million)
5.1.3 TRUFILL n Butyl Cyano Acrylate (nBCA) Liquid Embolic System
5.1.3.1 Global TRUFILL nBCA Liquid Embolic Systems Market Revenue, 2012 - 2020 (USD Million)
5.2 Recent Developments
5.3 Competitive Analysis
5.3.1 Market Share Analysis: Liquid Embolics, by Key Players, 2013 (Value %)

Chapter 6 Global Nanoparticles Market Revenue
6.1 Overview
6.1.1 Global Nano-enabled Drug Delivery Systems in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
6.1.2 Approved Nano-enabled Drug Delivery Systems for Cancer Treatment
6.1.3 Nano-enabled Drug Delivery Systems in Cancer Treatment Under Clinical Investigation
6.1.4 Emerging Technologies and Treatments
6.1.4.1 Nanocarriers
6.2 Competitive Analysis
6.2.1 Market Share Analysis: Nanoparticles, by Key Players, 2013 (Value %)

Chapter 7 Global NDDS in Cancer Therapy Market, by Geography
7.1 Overview
7.1.1 Global NDDS in Cancer Therapy Market Revenue, by Geography, 2012 - 2020 (USD Million)
7.2 North America
7.2.1 North America NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
7.2.2 North America NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)
7.3 Europe
7.3.1 Europe NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
7.3.2 Europe NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
7.4.2 Asia Pacific NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)
7.5 Rest of the World
7.5.1 Rest of the World NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
7.5.2 Rest of the World NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)

Chapter 8 Recommendations
8.1 Strategies for Success
8.2 ANSOFF Matrix
List of Figures

FIG. 1 Market Segmentation: NDDS in Cancer Therapy
FIG. 2 Global NDDS in Cancer Therapy Market, by Technology, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global NDDS in Cancer Therapy Market Revenue, by Geography, 2013 and 2020 (Value %)
FIG. 4 Global Historical Prevalence (Number of Cases), by Major Cancer Type (2008 - 2012)
FIG. 5 Global Prevalence Forecast (Number of Cases), by Major Cancer Type (2013 - 2020)
FIG. 6 Global Historical Incidence (Number of Cases), by Major Cancer Type (2008 - 2012)
FIG. 7 Global Incidence Forecast (Number of Cases), by Major Cancer Type (2013 - 2020)
FIG. 8 Major Steps: U.S. FDA Regulatory Approval Pathway
FIG. 9 Major Steps: CE Marking Regulatory Approval Pathway
FIG. 10 Market Attractiveness Analysis: Global NDDS in Cancer Therapy Market, by Geography
FIG. 11 Global Drug Eluting Beads Market Revenue, 2012 - 2020 (USD Million)
FIG. 12 Global Other Current Technologies Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Global SIRT/ Radioembolization Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Global SIR-Spheres Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Global TheraSphere Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Market Share Analysis: Embolization Particles, by Key Players, 2013 (Value %)
FIG. 17 Global Onyx Devices Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Global TRUFILL nBCA Liquid Embolic Systems Market Revenue, 2012 - 2020 (USD Million)
FIG. 19 Market Share Analysis: Liquid Embolics, by Key Players, 2013 (Value %)
FIG. 20 Global Nano-enabled Drug Delivery Systems in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
FIG. 21 Market Share Analysis: Nanoparticles, by Key Players, 2013 (Value %)
FIG. 22 North America NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
FIG. 23 Europe NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
FIG. 24 Asia Pacific NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
FIG. 25 Rest of the World NDDS in Cancer Therapy Market Revenue, 2012 - 2020 (USD Million)
FIG. 26 ANSOFF Matrix: NDDS in Cancer Therapy Market
List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global NDDS in Cancer Therapy Market (2013 and 2020)
TABLE 3 Event Impact Analysis: Global NDDS in Cancer Therapy Market
TABLE 4 Global Embolization Particles Market Revenue, by Type, 2012 - 2020 (USD Million)
TABLE 5 Global Liquid Embolics Market Revenue (Forecast), by Brand, 2012 - 2020 (USD Million)
TABLE 6 Approved Nano-enabled Drug Delivery Systems for Cancer Treatment
TABLE 7 Nano-enabled Drug Delivery Systems in Cancer Treatment Under Clinical Investigation
TABLE 8 Global NDDS in Cancer Therapy Market Revenue, by Geography, 2012 - 2020 (USD Million)
TABLE 9 North America NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)
TABLE 10 Europe NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)
TABLE 11 Asia Pacific NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)
TABLE 12 Rest of the World NDDS in Cancer Therapy Market Revenue, by Technology, 2012 - 2020 (USD Million)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.